☰ Menu

Training Course in Sexual and Reproductive Health Research 2014 - List of participants

Tarek Al-Hussaini

Women's Health Hospital, Faculty of Medicine, Assiut University, Assiut, Egypt

Tarek Al-Hussaini

Tarek K. Al-Hussaini, MD, FRCOG
Professor and Consultant in Obstetrics and Gynecology, Women's Health Hospital, Faculty of Medicine, Assiut University, Assiut, Egypt

Tarek Al-Hussaini qualified in Medicine in 1984 from Assiut University, Egypt. After 3 years of residency his MSc was awarded in 1988. Following clinical and research posts at the Department of Obstetrics and Gynecology, Assiut University (Egypt), and IVF Unit at Kiel`s Frauenklinik (Germany), he was awarded his MD degree in 1993 and was then appointed as a lecturer in Obstetrics and Gynecology at Assiut University in 1994. He was awarded MRCOG in 1997 after spending 18 months as a specialist registrar at the Royal Infirmary of Edinburgh and Simpson's Memorial Maternity Pavilion (Scotland). In February 1999 he became an assistant professor and consultant and in February 2004 he was appointed as a Professor in Obstetrics and Gynecology, Faculty of Medicine, Assiut University. He was promoted by the RCOG to be a fellow (FRCOG) in September 2010. He was awarded many local and national prestigious awards. One of his main interests is women`s health with special emphasis on research designed to reduce maternal mortality/morbidity, violence against women and management of high risk pregnancies. He participated in more than five multicenter international trials which changed the practice of Obstetrics in the past 15 years as the Term Breech Trial, the Magpie trial, Early ECV 1 and 2 and The PROMISS trial.

Publications listed in PubMed

  • Mahadevan S, Wen S, Balasa A, Fruhman G, Mateus J, Wagner A, Al-Hussaini T, Van den Veyver IB. No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform moles. Prenat Diagn. 2013 Dec;33(13):1242–7.
  • Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, G├╝lmezoglu AM. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. J Matern Fetal Neonatal Med. 2013 Nov;26(17):1705–9.
  • Hutton EK, Hannah ME, Ross SJ, Delisle M-F, Carson GD, Windrim R, Ohlsson A, Willan AR, Gafni A, Sylvestre G, Natale R, Barrett Y, Pollard JK, Dunn MS, Turtle P, Early ECV2 Trial Collaborative Group. The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies. BJOG. 2011 Apr;118(5):564–77.
  • Miller S, Fathalla MMF, Youssif MM, Turan J, Camlin C, Al-Hussaini TK, Butrick E, Meyer C. A comparative study of the non-pneumatic anti-shock garment for the treatment of obstetric hemorrhage in Egypt. Int J Gynaecol Obstet. 2010 Apr;109(1):20–4.
  • Mourad-Youssif M, Ojengbede OA, Meyer CD, Fathalla M, Morhason-Bello IO, Galadanci H, Camlin C, Nsima D, Al Hussaini T, Butrick E, Miller S. Can the Non-pneumatic Anti-Shock Garment (NASG) reduce adverse maternal outcomes from postpartum hemorrhage? Evidence from Egypt and Nigeria. Reprod Health. 2010;724.
  • Miller S, Fathalla MMF, Ojengbede OA, Camlin C, Mourad-Youssif M, Morhason-Bello IO, Galadanci H, Nsima D, Butrick E, Al Hussaini T, Turan J, Meyer C, Martin H, Mohammed AI. Obstetric hemorrhage and shock management: using the low technology Non-pneumatic Anti-Shock Garment in Nigerian and Egyptian tertiary care facilities. BMC Pregnancy Childbirth. 2010;1064.
  • Bricker L, Peden H, Tomlinson AJ, Al-Hussaini TK, Idama T, Candelier C, Luckas M, Furniss H, Davies A, Kumar B, Roberts J, Alfirevic Z. Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial. BJOG. 2008 Nov;115(12):1503–11.
  • Kou YC, Shao L, Peng HH, Rosetta R, del Gaudio D, Wagner AF, Al-Hussaini TK, Van den Veyver IB. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod. 2008 Jan;14(1):33–40.
  • Van den Veyver IB, Al-Hussaini TK. Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring. Hum Reprod Update. 2006 Jun;12(3):233–42.
  • Panichkul PC, Al-Hussaini TK, Sierra R, Kashork CD, Popek EJ, Stockton DW, Van den Veyver IB. Recurrent biparental hydatidiform mole: additional evidence for a 1.1-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol Investig. 2005 Jul;12(5):376–83.
  • Al-Hussaini TK, Abd el -Aal DM, Van den Veyver IB. Recurrent pregnancy loss due to familial and non-familial habitual molar pregnancy. Int J Gynaecol Obstet. 2003 Nov;83(2):179–86.
  • Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH. Second-trimester pregnancy termination: comparison of three different methods. J Obstet Gynaecol. 2003 Jul;23(4):407–11.
  • Al-Hussaini TK, Abdel-Aal SA, Youssef M a. M. Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term. Int J Gynaecol Obstet. 2003 Jul;82(1):73–5.
  • Al-Hussaini TK. Female genital cutting: types, motives and perineal damage in laboring Egyptian women. Med Princ Pract. 2003 Jun;12(2):123–8.
  • Al-Hussaini TK. Uterine rupture in second trimester abortion in a grand multiparous woman. A complication of misoprostol and oxytocin. Eur J Obstet Gynecol Reprod Biol. 2001 Jun;96(2):218–9.
  • Al-Hussaini TK, Abdel-Alim MA. Habitual complete molar pregnancy: a case report. Reprod Biomed Online. 2001;3(2):133–5.
  • Abdel-Aleem H, Al-Hussaini T, Karoush S. Hyperreactio luteinalis associated with normal singleton pregnancy. J Obstet Gynaecol. 2000 May;20(3):315.
  • Al-Hussaini TK, Abol-Ella HA. Three steps management of irreducible complete procidentia complicated by vesical calculi. J Obstet Gynaecol. 1999 Sep;19(5):551–2.
  • al-Hussaini T, Mettler L. Recurrent ectopic pregnancy following in-vitro fertilization. Hum Reprod. 1992 Nov;7(10):1479–80.
  • al-Hussaini T, Mettler L, Ibrahim M, Buck S. Pregnancies following transvaginal gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and tubal embryo-stage transfer (TEST) in an in vitro fertilization (IVF) program. J Assist Reprod Genet. 1992 Aug;9(4):402–4.